Showing 3 posts of 3 posts found.


NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy

January 4, 2018
Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …


GSK’s gene therapy Strimvelis gets European regulatory nod

June 1, 2016
Research and Development, Sales and Marketing EU, European Commission, GlaxoSmithKline, Strimvelis, gene therapy, regulation

UK drugmaker GlaxoSmithKline (LSE: GSK) said its gene therapy Strimvelis has secured backing from the European regulators. The European Commission …

Latest content